© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Clinafloxacin stands as a fluoroquinolone antibiotic recognized for its strong action against both Gram-positive and Gram-negative bacteria, including stubborn strains that evade many standard treatments. Used mainly for research and development, it carries a unique edge due to its chemical structure. Years ago, researchers in the lab worked with this substance to target infections that frustrated doctors and patients alike. Clinafloxacin offers a window into how science pushes forward, often beyond what is immediately available on pharmacy shelves.
The molecular formula for Clinafloxacin is C17H18ClFN4O4, and it brings a specific set of atoms together in a way that grants it both potency and certain risks. In my own experience, handling powdered forms of fluoroquinolones required close attention: the molecular weight, 396.8 g/mol, may seem minor to some, yet it affects everything from raw handling to eventual solubility in lab solutions. Every time a chemist sets up an experiment with Clinafloxacin, the presence of both fluorine and chlorine atoms in the molecule signals potential for aggressive biological action and the importance of careful stewardship.
Clinafloxacin usually appears as a solid, presenting in flake or crystalline powder forms. Its color shifts from white to off-white, a subtle but important visual cue when assessing material purity or degradation during storage. Density sits around 1.62 g/cm3, placing it in the mid-range for laboratory chemicals, which means standard handling equipment usually does the job unless precise weight or volume is required. With a melting point near 240-244°C, this solid stays stable under most room-temperature conditions, but heating beyond that quickly moves it toward decomposition. In research, the look and feel of a sample often tell the story. If a batch shifts to a sticky or caked consistency, something’s gone wrong—maybe moisture crept in, or storage temperatures slipped. Each of these experiences makes clear just how variable and demanding raw chemical materials can be.
Laboratories often dissolve Clinafloxacin in water, dimethyl sulfoxide, or other solvents to achieve the concentrations needed for biological testing. In my own lab, getting a truly clear solution often depended not just on solvent choice, but also on the gentle warming and occasional filtration to remove particulates. Some researchers prefer working with a liter solution at a fixed molarity, while others scale down to milliliter samples. Whether a powder, pearl, or crystal, the choice hinges on downstream uses: solid forms store longer, solutions act faster in experiments. Reading through hundreds of material data sheets, one lesson always sticks—every property, from solubility to crystal form, influences results, safety, and the cost of wasted time.
Globally, Clinafloxacin falls under HS Code 29419090 for customs and trade. This category covers antibiotics not elsewhere specified and requires detailed documentation at every shipping checkpoint. Bringing in raw materials for my own projects once required weeks of lead time, since customs reviewed these compounds for both trade compliance and safety. Specifications tied to this chemical go beyond the molecular formula; assay purity, moisture content, and residual solvents all play a role. A typical certificate of analysis lists each detail—laboratories depend on this transparency to trust the results of any new batch. Sourcing raw materials with verified certificates builds reliability, and each error or slip-up can jeopardize not only data, but also health and finances.
Clinafloxacin, like many fluoroquinolones, brings health hazards if misused. It can cause adverse effects with repeated exposure, especially through inhalation or skin contact in powder form. In my experience, direct contact prompted skin tingling, which highlighted the need for gloves, lab coats, and proper ventilation at every workstation. Chemical safety data sheets mark it as harmful or hazardous and call for standard precautions: avoid creating dust, keep containers tightly closed, and store out of reach of those without chemical training. Disposal deserves special attention, as this material cannot simply head down the drain. Even a slight mistake—spilled powder, misplaced container—prompts a time-consuming cleanup and paperwork trail. Risk management doesn't end with the experiment; it carries through every shipment, every storage shelf, and every waste stream.
Medical and research communities keep an eye on Clinafloxacin due to its unique profile, but safety concerns and regulatory scrutiny now shape its use more than ever. In my own role, staying ahead of required controls, handling protocols, and sourcing only from verified suppliers protects both humans and the environment. Fact-based communication about properties—like molecular weight, density, and hazard information—goes a long way in keeping everyone safe. A strong safety culture makes every difference; it depends on hands-on training, clear documentation, and a willingness to question every shipment and every protocol before use. The importance of reliable raw materials, proper labeling, and responsible chemical stewardship runs through every story of scientific success, and that's the lesson Clinafloxacin continues to teach in labs around the world.
